Clinical Trials Browser

Phase 2 × INDUSTRY × Ovarian Cancer Recurrent × Clear all

IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer